TY - JOUR
T1 - Longitudinal study of the effects of bacteremia and sepsis on 5-year risk of cardiovascular events
AU - Jafarzadeh, S. Reza
AU - Thomas, Benjamin S.
AU - Warren, David K.
AU - Gill, Jeff
AU - Fraser, Victoria J.
N1 - Funding Information:
This work was supported by the Prevention Epicenters Program of the CDC (grant number U54 CK000162) and the Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (grant number UL1 TR000448). V. J. F. reports grant funding from the CDC and the NIH
Publisher Copyright:
© 2016 The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
PY - 2016/8/15
Y1 - 2016/8/15
N2 - Background. The long-term and cumulative effect of multiple episodes of bacteremia and sepsis across multiple hospitalizations on the development of cardiovascular (CV) events is uncertain. Methods. We conducted a longitudinal study of 156 380 hospitalizations in 47 009 patients (≥18 years old) who had at least 2 inpatient admissions at an academic tertiary care center in St Louis, Missouri, from 1 January 2008 through 31 December 2012. We used marginal structural models, estimated by inverse probability weighting (IPW) of bacteremia or sepsis and IPW of censoring, to estimate the marginal causal effects of bacteremia and sepsis on developing the first observed incident CV event, including stroke, transient ischemic attack, and myocardial infarction (MI), during the study period. Results. Bacteremia and sepsis occurred during 4923 (3.1%) and 5544 (3.5%) hospitalizations among 3932 (8.4%) and 4474 (9.5%) patients, respectively. CV events occurred in 414 (10.5%) and 538 (12.0%) patients with prior episodes of bacteremia or sepsis, respectively, vs 3087 (7.2%) and 2963 (7.0%) patients without prior episodes of bacteremia or sepsis. The causal odds of experiencing a CV event was 1.52-fold (95% confidence interval [CI], 1.21- to 1.90-fold) and 2.39-fold (95% CI, 1.88- to 3.03-fold) higher in patients with prior instances of bacteremia or sepsis, respectively, compared to those without. Prior instances of septic shock resulted in a 6.91-fold (95% CI, 5.34- to 8.93-fold) increase in the odds of MI. Conclusions. Prior instances of bacteremia and sepsis substantially increase the 5-year risk of CV events.
AB - Background. The long-term and cumulative effect of multiple episodes of bacteremia and sepsis across multiple hospitalizations on the development of cardiovascular (CV) events is uncertain. Methods. We conducted a longitudinal study of 156 380 hospitalizations in 47 009 patients (≥18 years old) who had at least 2 inpatient admissions at an academic tertiary care center in St Louis, Missouri, from 1 January 2008 through 31 December 2012. We used marginal structural models, estimated by inverse probability weighting (IPW) of bacteremia or sepsis and IPW of censoring, to estimate the marginal causal effects of bacteremia and sepsis on developing the first observed incident CV event, including stroke, transient ischemic attack, and myocardial infarction (MI), during the study period. Results. Bacteremia and sepsis occurred during 4923 (3.1%) and 5544 (3.5%) hospitalizations among 3932 (8.4%) and 4474 (9.5%) patients, respectively. CV events occurred in 414 (10.5%) and 538 (12.0%) patients with prior episodes of bacteremia or sepsis, respectively, vs 3087 (7.2%) and 2963 (7.0%) patients without prior episodes of bacteremia or sepsis. The causal odds of experiencing a CV event was 1.52-fold (95% confidence interval [CI], 1.21- to 1.90-fold) and 2.39-fold (95% CI, 1.88- to 3.03-fold) higher in patients with prior instances of bacteremia or sepsis, respectively, compared to those without. Prior instances of septic shock resulted in a 6.91-fold (95% CI, 5.34- to 8.93-fold) increase in the odds of MI. Conclusions. Prior instances of bacteremia and sepsis substantially increase the 5-year risk of CV events.
KW - Bloodstream infection
KW - Causal inference
KW - Inverse probability weighting
KW - Marginal structural model
KW - Time-varying confounding
UR - http://www.scopus.com/inward/record.url?scp=84982085571&partnerID=8YFLogxK
U2 - 10.1093/cid/ciw320
DO - 10.1093/cid/ciw320
M3 - Article
C2 - 27193746
AN - SCOPUS:84982085571
SN - 1058-4838
VL - 63
SP - 495
EP - 500
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -